08:56 AM EST, 01/08/2025 (MT Newswires) -- Health care stocks were steady premarket Wednesday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was up 0.1% recently.

Halozyme Therapeutics ( HALO ) shares were 5% higher after the company raised its 2025 adjusted earnings per share and revenue guidance driven by higher royalty revenue and increased product sales from its Xyosted treatment.